Doctors are hailing a new treatment for the lung disease cystic fibrosis as a hugely significant advancement. A study in the New England Journal of Medicine says the drug called “ivacaftor” targets a faulty protein that causes the disease by correcting the balance of salt and water in the patient’s airways. Those who took the […]